Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02EEK
|
||||
Former ID |
DNCL002663
|
||||
Drug Name |
J 591 Lu-177
|
||||
Indication | Metastatic prostate cancer; Non-metastatic prostate cancer [ICD9: 140-229, 185; ICD10:C61] | Phase 2 | [532377] | ||
Company |
BZL Biologics
|
||||
Target and Pathway | |||||
Target(s) | Glutamate carboxypeptidase II | Target Info | Modulator | [532377] | |
NetPath Pathway | TCR Signaling Pathway | ||||
TNFalpha Signaling Pathway | |||||
WikiPathways | One Carbon Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.